Laura A Vella-Geynisman

Title: Innovations of Laura A Vella-Geynisman

Introduction

Laura A Vella-Geynisman is an accomplished inventor based in Chicago, IL. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides derived from cyclin B1. Her work has the potential to impact various applications in medical research and therapeutics.

Latest Patents

Laura A Vella-Geynisman holds a patent for "Polypeptides derived from cyclin B1 and uses thereof." This invention provides a composition comprising one or more polypeptides, each consisting of sequences selected from a specific group. The polypeptides include KFRLLQETMYMTVSI (SEQ ID NO: 1), LQETMYMTVSIIDRF (SEQ ID NO: 2), and MYMTVSIIDRFM (SEQ ID NO: 3). Each polypeptide consists of at most 24 amino acid residues, and the composition also includes a carrier. Additionally, the invention encompasses compositions comprising bacterial or viral vectors that encode these polypeptides.

Career Highlights

Laura A Vella-Geynisman is affiliated with the University of Pittsburgh, where she continues her research and innovation in biotechnology. Her work has garnered attention for its potential applications in various fields, including cancer research and therapeutic development.

Collaborations

Laura collaborates with Olivera J Finn, who is also a prominent figure in the field. Their partnership enhances the research efforts and broadens the scope of their innovations.

Conclusion

Laura A Vella-Geynisman's contributions to biotechnology through her innovative patents and collaborations highlight her role as a significant inventor in her field. Her work continues to pave the way for advancements in medical research and applications.